CO6670570A2 - Pirimidinadas y tirazinas condensadas y su uso - Google Patents

Pirimidinadas y tirazinas condensadas y su uso

Info

Publication number
CO6670570A2
CO6670570A2 CO13003185A CO13003185A CO6670570A2 CO 6670570 A2 CO6670570 A2 CO 6670570A2 CO 13003185 A CO13003185 A CO 13003185A CO 13003185 A CO13003185 A CO 13003185A CO 6670570 A2 CO6670570 A2 CO 6670570A2
Authority
CO
Colombia
Prior art keywords
condensed
treatment
tirazins
pyrimidinated
prevention
Prior art date
Application number
CO13003185A
Other languages
English (en)
Spanish (es)
Inventor
Markus Follmann
Johannes-Peter Stasch
Gorden Redlich
Jens Ackerstaff
Dormagen Griebenow
Andreas Knorr
Frank Wunder
Volkhart Li
Walter Kroh
Lars Barfacker
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of CO6670570A2 publication Critical patent/CO6670570A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CO13003185A 2010-07-09 2013-01-09 Pirimidinadas y tirazinas condensadas y su uso CO6670570A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102010031149A DE102010031149A1 (de) 2010-07-09 2010-07-09 Annellierte Pyrimidine und Triazine und ihre Verwendung

Publications (1)

Publication Number Publication Date
CO6670570A2 true CO6670570A2 (es) 2013-05-15

Family

ID=45372624

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13003185A CO6670570A2 (es) 2010-07-09 2013-01-09 Pirimidinadas y tirazinas condensadas y su uso

Country Status (2)

Country Link
CO (1) CO6670570A2 (de)
DE (1) DE102010031149A1 (de)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9314412D0 (en) 1993-07-13 1993-08-25 Rhone Poulenc Agriculture New compositions of matter
DE19642255A1 (de) 1996-10-14 1998-04-16 Bayer Ag Verwendung von 1-Benzyl-3-(substituierten-hetaryl) -kondensierten Pyrazol-Derivaten
DE19834044A1 (de) 1998-07-29 2000-02-03 Bayer Ag Neue substituierte Pyrazolderivate
DE10220570A1 (de) 2002-05-08 2003-11-20 Bayer Ag Carbamat-substituierte Pyrazolopyridine
DE10317305B4 (de) 2003-04-14 2006-04-13 Carcoustics Tech Center Gmbh Abdeckung für ein Aggregat im Motorraum eines Kraftfahrzeuges
CA2521695C (en) 2003-05-09 2011-08-16 Asahi Glass Company, Limited Method for producing 3-substituted 2-chloro-5-fluoro-pyridine or its salt
ATE433452T1 (de) 2004-01-31 2009-06-15 Actimis Pharmaceuticals Inc Imidazoä1,2-cüpyrimidinylessigsäurederivate
WO2006130673A1 (en) 2005-05-31 2006-12-07 Janssen Pharmaceutica, N.V. 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
AU2008282156B2 (en) 2007-07-31 2014-07-17 Vertex Pharmaceuticals Incorporated Process for preparing 5-fluoro-1H-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
US8741910B2 (en) 2008-11-25 2014-06-03 Merck Sharp & Dohme Corp. Soluble guanylate cyclase activators

Also Published As

Publication number Publication date
DE102010031149A1 (de) 2012-01-12

Similar Documents

Publication Publication Date Title
ECSP13012379A (es) Pirimidinas y triazinas condensadas y su uso
DOP2014000160A (es) Pirimidinas y triazinas fusionadas sustituidas y su uso
DOP2014000043A (es) Pirimidinas anilladas sustituidas y uso de las mismas
GT201200250A (es) Ariltriazolonas ligadas a bisarilo y su uso
ECSP12012310A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
CO7131375A2 (es) Uracilos sustituidos bicíclicamente y uso de los mismos
ECSP13012668A (es) Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso
GT201300243A (es) Derivados de ácido 3-fenilpropiónico ramificados y su uso
PA8770101A1 (es) Amidas de 4-aril-1,4-dihidro-1, 6-naftiridina sustituidas y su uso
ECSP15001882A (es) Ácidos 5-aminotetrahidroquinolin-2-carboxílicos novedosos y su uso
HN2011002406A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
CL2013003372A1 (es) Compuestos derivados de espiro-[1,3]-oxacinas y espiro-[1,4]-oxacepinas, inhibidores de bace1 y/o bace2; composicion farmaceutica; procedimiento para prepararlos; y su uso en el tratamiento y/o la profilaxis de la enfermedad de alzheimer y diabetes.
SV2010003581A (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
UY35350A (es) Pirimidinas condensadas sustituidas con trifluorometilo y su uso
UY31228A1 (es) Ariloxazoles sustituidos y su uso
CR20110318A (es) Compuestos, composición farmacéutica y métodos para utilizarse en el tratamiento de trastornos metabólicos
CU20100111A7 (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso para el tratamiento y prevención de enfermedades pulmonares y cardiovasculares
DOP2016000076A (es) Tienouracilcarboxamidas cíclicas y usos de las mismas
CO6670570A2 (es) Pirimidinadas y tirazinas condensadas y su uso
CU20100260A7 (es) 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos

Legal Events

Date Code Title Description
FG Application granted